Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Chelidonium majus (Papaveraceae)

Natural Product Communications

Volumn 5, Issue 11, 2010, Pages 1751-1754

  Cahlíková, Lucie ^a   Opletal, Lubomír ^a   Kurfürst, Milan ^b   Macáková, Kateřina ^a   Kulhánková, Andrea ^a   Hošt'álková, Anna ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b INSTITUTE OF CHEMICAL PROCESS FUNDAMENTALS   (Czech Republic)

Author keywords

6 ethoxydihydrosanguinarine; 6 ethoxydihydrochelerythrine; Acetylcholinesterase; Alzheimer?s disease; Butyrylcholinesterase; Chelidonium majus; Isoquinoline alkaloids; Papaveraceae; Red blood cells

Indexed keywords

6 ETHOXYDIHYDROCHELERYTHRINE; 6 ETHOXYDIHYDROSANGUINARINE; ACETYLCHOLINESTERASE; ALLOCRYPTOPINE; CHELIDONINE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; HOMOCHELIDONINE; ISOQUINOLINE ALKALOID; PROTOPINE; STYLOPINE; UNCLASSIFIED DRUG;

ARTICLE; ARTIFACT; CHELIDONIUM; CHOLINESTERASE BLOOD LEVEL; CHOLINESTERASE INHIBITION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CRYSTALLIZATION; DOSE RESPONSE; DRUG ACTIVITY; ERYTHROCYTE GHOST; HUMAN; HUMAN CELL; IC 50; NONHUMAN; PLANT ROOT; THIN LAYER CHROMATOGRAPHY;

CHELIDONIUM MAJUS; PAPAVERACEAE;

EID: 78751677593     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1000501110     Document Type: Article

References (27)

1. Lahiri DK, Farlow MR, Greig NH, Sambamurti K. (2002) Current drug targets for Alzheimer?s disease treatment. Drug Development Research, 56, 267-281. (Pubitemid 35168304)
2. Rahman AU, Coudhary MI. (2001) Bioactive natural products as a potential source of new pharmacophores a theory of memory. Pure and Applied Chemistry, 73, 555-560.
3. Greig NH, Lahiri DK, Sambamurti K. (2002) Butyrylcholinesterase: an important new target in Alzheimer?s disease therapy. International Psychogeriatrics, 14, 77-91.
4. Lleó A. (2007) Current therapeutic options for Alzheimer?s disease. Current Genomics, 8, 550-558. (Pubitemid 351472402)
5. Recanatini M, Valenti P. (2004) Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer?s disease therapeutics. Current Pharmaceutical Design, 10, 3157-3166. (Pubitemid 39242910)
6. Berkov S, Bastida J, Nikolova M, Viladomat F, Codina C. (2008) Rapid TLC/GC-MS identification of acetylcholinesterase inhibitors in alkaloid extracts. Phytochemical Analysis, 19, 411-419.
7. Hostettmann K, Borloz A, Urbain A, Marston A. (2006) Natural product inhibitors of acetylcholinesterase. Current Organic Chemistry, 10, 825-847
8. Colombo ML, Bosisio E. (1996) Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacological Research, 33, 127-134.
9. Tomé F, Colombo ML (1995) Alkaloids from Chelidonium majus: distribution in the plants and factors affecting their accumulation. Phytochemistry, 40, 37-39.
10. Slavík J, Slavíková L. (1977) Minor alkaloids from Chelidonium majus L. Collection of Czechoslovak Chemical Communications, 42, 2686-2693.
11. Cohen HG, Seifen EE, Straub KD, Tiefnback C, Stermitz FR. (1978) Structural specifity of the NaK-ATPase inhibition by sanquinarine, an isoquinoline benzophenanthridine alkaloid. Biochemical Pharmacology, 27, 2555-2558.
12. Lenfeld J, Kroutil M, Marsalek E, Slavik J, Preininger V, Simanek V. (1981) Antiinflamantory activity of quaternary benzophenanthridine alkaloids from Chelidonium majus. Planta Medica, 43, 161-165. (Pubitemid 12206675)
13. Cho KM, Yoo ID, Kim WG (2006) 8-Hydroxydihydrochelerythrine and 8-hydroxydihydrosanquinarine with a potent acetylcholinesterase inhibitory activity from Chelidonium majus L. Biological and Pharmaceutical Bulletin, 29, 2317-2320.
14. Kiryakov HG, Iskrenova E, Daskalova E, Kuzmanov B, Evstatieva, L. (1982) Alkaloids of Corydalis slivenesis. Planta Medica, 44, 168-170.
15. Weinguang Z, Wenzao L, Guoshi T. (1987) Chemical study of alkaloids from Corydalis bungeana. Planta Medica, 53, 418-420.
16. Takao N, Kamiguachi M, Iwasa K, Morita N, Kuriyama K. (1984) Stereochemistry of hydrobenzo[c]phenanthridine alkaloids. Optical properties and absolute configuration of (+)-14-epicoridine, (+)-corydine, (+)-chelidonine and releated compounds. Archiv der Pharmazie, 317, 223-237. (Pubitemid 14155088)
17. Toušek J, Dommisse R, Dostál J, Žák Z, Pieters L, Marek R. (2002) Configuration and conformation of sanguinarine and chelerythrine free bases stereoisomers. Journal of Molecular Structure, 613, 102-113.
18. Marek R, Sečkářová P, Hulová D, Marek J, Dostál J, Sklenář (2003) Palmatine and berberine isolation artifacts. Journal of Natural Products, 66, 481-486.
19. Dostál J, Táborská E, Slavík J. (1995) Structure of chelerythrine base. Journal of Natural Products, 58, 723-729.
20. Dostál J, Marek R, Slavík J, Táborská E, Potáček M, Sklenář V. (1998) Sanguinarine pseudobase: re-examination of NMR assigments using gradient-enhanced spectroscopy. Magnetic Resonance in Chemistry, 36, 869-872.
21. Cahlíková L, Macáková K, Kuneš J, Kurfürst M, Opletal L, Cvačka J, Chlebek J, Blunden G. (2010) Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Eschscholzia californica (Papaveraceae). Natural Product Communications, 5, 1035-1038.
22. Ellman GL, Courtney KD, Andres V, Featherstone RM. (1961) A new rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7, 88-95.
23. Whiteley CG, Daya S. (1995) Protein ligand interactions. Part 5: Isoquinoline alkaloids as inhibitors of acetylcholinesterase from Electrophorus electricus. Journal of Enzyme Inhibition, 9, 285-294.
24. Khorana N, Markmee S, Ingkaninan K, Ruchirawat S, Kitbunnadaj R, Pullagurla MR. (2009) Evaluation of new lead for acetylcholinesterase inhibition. Medicinal Chemistry Research, 18, 231-241.
25. Kuznetsova LP, Nikol?skaya EB, Sochilina EE, Faddeeva MD. (2002) Inhibition of human blood acetylcholinesterase and butyrylcholinesterase by some alkaloids. Journal of Evolutionary Biochemistry and Physiology, 38, 35-39.
26. Ulrichová J, Walterová D, Preininger V, Slavík J, Lenfeld J, Cushman M, Šimánek V. (1983) Inhibition of acetylcholinesterase activity by some isoquinoline alkaloids. Planta Medica, 48, 111-115.
27. Steck TL, Kant JA. (1974) Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods in Enzymology, 31 (Pt A), 172-180.